PUBLISHED DATE : Jul 2022 | Pages : 378
Fill out your details & get your free sample
Global Synthetic Biology Market Size, Share, & Trends Analysis Report by
Industry Analysis Report, Regional Outlook, Growth Potential, Price Trends, Competitive Market Share & Forecast, 2022–2027
378 Pages
187 Tables
185 Charts
5 Regions
18 Countries
26 Companies
5 Market Segment
| Report Attribute | Details |
|---|---|
| Market Size (2027) | USD 38.73 Billion |
| Market Size (2021) | USD 10.13 Billion |
| CAGR (2022-2027) | 25.05% |
| Base Year | 2021 |
| Forecast Year | 2022-2027 |
| Market Segments | Tools, Technology, Application, End-user, and Geography |
| Geographic Analysis | North America, Europe, APAC, Latin America, and Middle East & Africa |
| Countries Covered | US, Canada, UK, Germany, France, ItalySpain, Japan, China, South Korea, Australia, India, Brazil, Mexico, Argentina, Turkey, South Africa, and Saudi Arabia |
The global synthetic biology market was valued at USD 10.13 billion in 2021 and is projected to reach USD 38.73 billion in 2027, growing at a CAGR of 25% during 2022 to 2027. Synthetic biology is a new interdisciplinary field that includes the application of engineering principles to biology. It intends to design and manufacture biological components and systems that do not yet exist in nature. Synthetic biology combines the chemical synthesis of DNA with increased knowledge of genetics to enable researchers to quickly create cataloged DNA sequences and assemble them into new genomes. With the improved speed and cost of DNA synthesis, scientists can use advanced biofuels, bioproducts, renewable chemicals, bio-based specialty chemicals, pharmaceutical intermediates, fine chemicals, and food ingredients.
For More Information on Investment Analysis and Forecast: Request a Free Sample Now!
Industrial biotechnology provides tools to improve the natural mechanisms of biological processes for the efficient production of enzymes, chemicals, polymers, and even daily necessities such as foods and fuels. Scientists have studied the genomes of microorganisms to identify biological processes that can replace chemical reactions, create new products, make manufacturing processes cleaner, and reduce the number of manufacturing steps. Industrial biotechnology innovations are now successfully competing and replacing traditional petrochemical manufacturing processes. Companies using synthetic biology believe that they can reduce costs, reduce pollution and carbon dioxide emissions, and increase profitability.
The various approaches that synthetic biology encompasses, such as the design of gene and protein circuits from standard biological parts, the development of synthetic genetic codes, and the creation of artificial cells and organisms, will undoubtedly allow for the application of knowledge in different branches of science and technology. Redesigning the existing biological parts expands the set of functions for biological processes. Synthetic biology can allow new perspectives and the creation of new biological innovations. Development of technology platforms or creating new or upgraded physical structures can be used to implement new functions and reap benefits.
The following factors will drive the global synthetic biology market growth:
Synthetic biology brings a paradigm shift in the field of biomedicine
Synthetic Biology offers modern approaches for engineering new biological systems or redesigning existing ones for practical purposes. CAR-T therapy has some crucial advantages that may not be available with other drugs used for cancer treatment.
The synthetic biology market is witnessing a significant rise in investments.
There is a massive inflow of investments for synthetic biology start-ups as they provide innovative market solutions. There are various pipeline products for the same. Some markets like Germany, China, and Italy are progressing toward a mature markets. In contrast, some regions like Africa do not have a significant number of companies or academic institutes for the same. In contrast, countries like India are in the nascent stages of synthetic biology. There are more opportunities in synthetic biology than challenges in the current scenario. Still, some ethical issues need to be addressed.
Synthetic biology products are transforming the world.
Synthetic biology has the potential to develop real-world applications. Synthetic biology can transform food, source materials, and medicines. Many biotechnologies, pharmaceutical, and agriculture companies best highlight applying synthetic biology tools developed from 2000–to 2021 and are available now or in the coming years. Over the next decade, more products will derive superior performance and affordability from engineering biology. The field is already impacting life sciences & pharmaceuticals, and industrial applications on a large scale.
North America: Factors driving the market's growth in the region include a wide range of synthetic biology applications, the rising R&D funding and growing initiatives in synthetic biology, the declining costs of genome sequencing and synthesis, and the increasing investments in the market. The synthetic biology market is growing and rapidly accelerating into industrial, food & agriculture, and environmental areas. The region also has highly advanced genomic labs and genomic research centers involved in conducting large-scale research projects per the market demand. They are collaborating with pharma and biotech companies across the world. In North America, a larger population is involved in agriculture practice. More than 3.2 million hectares of land are used for organic farming alone. This region has one of the largest genetically modified (GM) crops approved, which can be grown to fulfill the demand in the market.
Europe: This region shows multiple research projects conducted in various European countries in Life Science segments. Europe stands second after the North American area in the genome sequencing field of cell and gene therapy. These fields demand extensive research and development infrastructure to handle complex analyses like sequencing millions of base pairs and analyzing complex data. The market players in this region are focusing on investment in R&D with notables competition among the prominent and emerging players.
APAC: The stringent regulatory requirements, and high cost of maintenance of the technology infrastructure, hamper the market's growth in the APAC region. The government support in most Asian countries accelerates the development of biopharmaceuticals in the region. Moreover, biosimilars manufacturing is expanding in developing countries, owing to affordability in production as it requires low per capita spending. Vaccine manufacturing is one segment that has primarily adopted the usage of synthetic biology in them for net yield and to reduce the cost of manufacturing in the market. In addition to this, it was observed in the agri-food sector with five Asian countries in the top 10 investment markets for agri-food receiving a considerable amount compared to the US the global funding.
Latin America: Latin America is home to many developing and underdeveloped countries. The usage of advanced biotechnology-related products like synthetic biology in the industries is moderate, as there is a lack of stringent regulatory requirements in manufacturing the products. The Latin American countries still lack developed infrastructure in various life sciences segments. Latin America will be a significant food processing market with an increased number of research labs and processing industries working. Latin American countries are elaborating the policy framework for developing the economy, which is underway in several countries. They also focus on building sustainable environmental conditions using synthetic biology tools in the market. Latin America is a major exporter of food & agricultural commodities, accounting for more than 16% of the global food & agriculture exports and 4% of the total food & agriculture imports.
Middle East & Africa: The opportunity for synthetic biology products like GM crops that can grow in extreme conditions and yield better are some options that synthetic biology can provide to some African countries. African countries face malnutrition, diseases, hunger, and pollution challenges, which can only be solved using synthetic biology products. Positive factors towards the adoption of synthetic biology are various foundations coming up in the country, Synbio Africa, which are tasked to harmonize the efforts of scientists, students, researchers, farmers, and policymakers to impact communities in Africa positively. The scenario in the middle east countries is different. Various advancements related to environmentally friendly products reduce pollution, as many refineries exist in the country. Exploring new products for research are also being performed in the middle east countries.
Tools Insights
Synthetic biology products are (re-)designed products of existing life forms or the creation of new life forms. Synthetic biology differs from traditional molecular and cellular biology because it focuses on developing and constructing tools that can be modeled, understood, and optimized to meet specific performance criteria. These smaller parts and devices are assembled into larger integrated systems to solve problems or yield better outcomes. The synthetic DNA market generated a significant chunk of revenue during the forecast period. Synthetic DNA is growing as an alternative to device-based technology in data storage, product labeling, and signal processing.
The enzymes market will grow at a CAGR of ~26% during the forecast period. Microbial-derived enzymes have great potential for waste management and, by extension, the development of an environment-friendly environment. Enzymes are effectively used in many industries for higher quality production with harmless environmental pollution and accelerated reaction rates with cost-efficiency.
Technology Insights
The synthetic biology applications require continued development of enabling & enabled technologies to ensure these technologies remain accessible for research. The enabling technologies are emerging rapidly and being applied in various healthcare, industrial, food & agricultural, and large-scale environmental projects. The applications of enabling technologies in synthetic biology are widely accepted.
Applications Insights
Synthetic biology offers a wide range of applications in biomedicine, therapeutics, diagnostics, and advanced therapies. The food & agriculture sector is also implementing genome-based research for new viable product development to overcome the modern solutions in modern days. By transforming biology by creating and developing bio-based therapies, chemicals, materials, fresh food, and energy sources, synthetic biology tools, technology, and engineering principles improve and protect the natural environment. General synthetic biology is applied in a wide range of fields, and it impacts the betterment of lives.
End-user Insights
The end-users widely accept the use and research scope of synthetic biology. Academic/research institutes & laboratories are the first point of research studies on synthetic biology tools and techniques. The research provides a deep understanding of tools and technologies for the potential impact of synthetic biology products in a particular segment or sector. The emergence and advancements in synthetic biology have significantly impacted the healthcare industry. Pharma & biotech companies are the platform for research investments and commercializing products in the market. The major players in the market raise funds for research and collaborate/acquire other institutes.
Frequently Asked Questions
WHAT IS THE MARKET VALUE OF THE GLOBAL SYNTHETIC BIOLOGY MARKET?
The global synthetic biology market size was valued at USD 10.13 billion in 2021 and is expected to reach USD 38.73 billion by 2027.
WHAT IS THE ESTIMATED GROWTH RATE OF THE GLOBAL SYNTHETIC BIOLOGY MARKET?
The global synthetic biology market is expected to grow at a CAGR of 25.05% during 2022-2027.
WHICH REGION HOLDS THE LARGEST SHARE IN THE GLOBAL SYNTHETIC BIOLOGY MARKET?
North America holds the largest share in the global synthetic biology market.
WHO ARE THE KEY PLAYERS IN THE GLOBAL SYNTHETIC BIOLOGY MARKET?
Key players include Agilent Technologies, Codexis, Eurofins Scientific, Illumina, Novozymes, and Thermo Fisher Scientific.
WHAT ARE THE GROWTH FACTORS DRIVING THE GLOBAL SYNTHETIC BIOLOGY MARKET?
The synthetic biology market witnessing a significant rise in investments, increasing strategic collaborations & acquisitions developing multifunctional products, and bringing transformative technologies to agriculture are the major growth factors driving the market.
The global synthetic biology market was valued at USD 10.13 billion in 2021 and is expected to reach USD 38.73 billion by 2027, growing at a CAGR of 25%.
Base Year: 2021
Forecast Year: 2022-2027
The study considers a detailed scenario of the present global synthetic biology market and its dynamics for 2022−2027. It covers a detailed overview of several market growth enablers, restraints, and trends. The report offers both the demand and supply aspects of the market. It profiles and examines leading companies and other prominent ones operating in the industry.
Key Vendors
Other Prominent Vendors
Segmentation by Tools
Segmentation by Technology
Segmentation by Application
Segmentation by End-user
Segmentation by Geography
1 RESEARCH METHODOLOGY
2 RESEARCH OBJECTIVES
3 RESEARCH PROCESS
4 SCOPE & COVERAGE
4.1 MARKET DEFINITION
4.1.1 INCLUSIONS
4.1.2 EXCLUSIONS
4.1.3 MARKET ESTIMATION CAVEATS
4.2 BASE YEAR
4.3 SCOPE OF THE STUDY
4.3.1 MARKET SEGMENTATION BY TOOLS
4.3.2 MARKET SEGMENTATION BY TECHNOLOGY
4.3.3 MARKET SEGMENTATION BY APPLICATIONS
4.3.4 MARKET SEGMENTATION BY END-USER
4.3.5 MARKET SEGMENTATION BY GEOGRAPHY
5 REPORT ASSUMPTIONS & CAVEATS
5.1 KEY CAVEATS
5.2 CURRENCY CONVERSION
5.3 MARKET DERIVATION
6 MARKET AT A GLANCE
7 INTRODUCTION
7.1 OVERVIEW
7.1.1 HISTORY OF SYNTHETIC BIOLOGY
7.1.2 SYNTHETIC BIOLOGY
8 MARKET OPPORTUNITIES & TRENDS
8.1 REAL-WORLD APPLICATIONS OF SYNTHETIC BIOLOGY PRODUCTS
8.2 SYNTHETIC BIOLOGY IN BIOMEDICINE
8.3 SYNTHETIC DNA AS A NEW STORAGE DEVICE
9 MARKET GROWTH ENABLERS
9.1 RISE IN MARKET INVESTMENTS
9.2 STRATEGIC COLLABORATIONS & ACQUISITIONS TO DEVELOP MULTIFUNCTIONAL PRODUCTS
9.3 TRANSFORMATIVE SYNTHETIC BIOLOGY TECHNOLOGIES IN AGRICULTURE
10 MARKET RESTRAINTS
10.1 MISUSE OF SYNTHETIC BIOLOGY
10.2 SYNTHETIC BIOLOGY-INDUCED CHANGES IN GLOBAL BIOSECURITY FRAMEWORK
10.3 THREAT TO EXISTING TECHNOLOGIES
11 MARKET LANDSCAPE
11.1 MARKET OVERVIEW
11.2 MARKET SIZE & FORECAST
11.2.1 GEOGRAPHY INSIGHTS
11.2.2 TOOLS INSIGHTS
11.2.3 TECHNOLOGY INSIGHTS
11.2.4 APPLICATIONS INSIGHTS
11.2.5 END-USER INSIGHTS
11.3 FIVE FORCES ANALYSIS
11.3.1 THREAT OF NEW ENTRANTS
11.3.2 BARGAINING POWER OF SUPPLIERS
11.3.3 BARGAINING POWER OF BUYERS
11.3.4 THREAT OF SUBSTITUTES
11.3.5 COMPETITIVE RIVALRY
12 TOOLS
12.1 MARKET SNAPSHOT & GROWTH ENGINE
12.2 MARKET OVERVIEW
12.3 OLIGONUCLEOTIDES & SYNTHETIC DNA
12.3.1 MARKET OVERVIEW
12.3.2 MARKET SIZE & FORECAST
12.3.3 OLIGONUCLEOTIDES & SYNTHETIC DNA SEGMENTATION BY GEOGRAPHY
12.4 ENZYMES
12.4.1 MARKET OVERVIEW
12.4.2 MARKET SIZE & FORECAST
12.4.3 ENZYMES SEGMENTATION BY GEOGRAPHY
12.5 CLONING TECHNOLOGY KITS
12.5.1 MARKET OVERVIEW
12.5.2 MARKET SIZE & FORECAST
12.5.3 CLONING TECHNOLOGY KITS SEGMENTATION BY GEOGRAPHY
12.6 XENO-NUCLEIC ACIDS
12.6.1 MARKET OVERVIEW
12.6.2 MARKET SIZE & FORECAST
12.6.3 XENO-NUCLEIC ACIDS SEGMENTATION BY GEOGRAPHY
12.7 CHASSIS ORGANISMS
12.7.1 MARKET OVERVIEW
12.7.2 MARKET SIZE & FORECAST
12.7.3 CHASSIS ORGANISMS SEGMENTATION BY GEOGRAPHY
13 TECHNOLOGY
13.1 MARKET SNAPSHOT & GROWTH ENGINE
13.2 MARKET OVERVIEW
13.3 ENABLING TECHNOLOGY
13.3.1 MARKET OVERVIEW
13.3.2 MARKET SIZE & FORECAST
13.3.3 ENABLING TECHNOLOGY SEGMENTATION BY GEOGRAPHY
13.4 ENABLED TECHNOLOGY
13.4.1 MARKET OVERVIEW
13.4.2 MARKET SIZE & FORECAST
13.4.3 ENABLED TECHNOLOGY SEGMENTATION BY GEOGRAPHY
14 APPLICATIONS
14.1 MARKET SNAPSHOT & GROWTH ENGINE
14.2 MARKET OVERVIEW
14.3 HEALTHCARE APPLICATIONS
14.3.1 MARKET OVERVIEW
14.3.2 MARKET SIZE & FORECAST
14.3.3 HEALTHCARE APPLICATIONS SEGMENTATION BY GEOGRAPHY
14.4 INDUSTRIAL APPLICATIONS
14.4.1 MARKET OVERVIEW
14.4.2 MARKET SIZE & FORECAST
14.4.3 INDUSTRIAL APPLICATIONS SEGMENTATION BY GEOGRAPHY
14.5 FOOD & AGRICULTURE APPLICATIONS
14.5.1 MARKET OVERVIEW
14.5.2 MARKET SIZE & FORECAST
14.5.3 FOOD & AGRICULTURE APPLICATIONS SEGMENTATION BY GEOGRAPHY
14.6 ENVIRONMENTAL APPLICATIONS
14.6.1 MARKET OVERVIEW
14.6.2 MARKET SIZE & FORECAST
14.6.3 ENVIRONMENTAL APPLICATIONS SEGMENTATION BY GEOGRAPHY
15 END-USER
15.1 MARKET SNAPSHOT & GROWTH ENGINE
15.2 MARKET OVERVIEW
15.3 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES
15.3.1 MARKET OVERVIEW
15.3.2 MARKET SIZE & FORECAST
15.3.3 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES SEGMENTATION BY GEOGRAPHY
15.4 PHARMA & BIOTECH COMPANIES
15.4.1 MARKET OVERVIEW
15.4.2 MARKET SIZE & FORECAST
15.4.3 PHARMA & BIOTECH COMPANIES SEGMENTATION BY GEOGRAPHY
15.5 OTHERS
15.5.1 MARKET OVERVIEW
15.5.2 MARKET SIZE & FORECAST
15.5.3 OTHERS SEGMENTATION BY GEOGRAPHY
16 GEOGRAPHY
16.1 MARKET SNAPSHOT & GROWTH ENGINE
16.2 GEOGRAPHIC OVERVIEW
17 NORTH AMERICA
17.1 MARKET OVERVIEW
17.2 MARKET SIZE & FORECAST
17.2.1 NORTH AMERICA BY TOOLS SEGMENTATION
17.2.2 NORTH AMERICA BY TECHNOLOGY SEGMENTATION
17.2.3 NORTH AMERICA BY APPLICATIONS SEGMENTATION
17.2.4 NORTH AMERICA BY END-USER SEGMENTATION
17.3 KEY COUNTRIES
17.3.1 US: MARKET SIZE & FORECAST
17.3.2 CANADA: MARKET SIZE & FORECAST
18 EUROPE
18.1 MARKET OVERVIEW
18.2 MARKET SIZE & FORECAST
18.2.1 EUROPE BY TOOLS SEGMENTATION
18.2.2 EUROPE BY TECHNOLOGY SEGMENTATION
18.2.3 EUROPE BY APPLICATIONS SEGMENTATION
18.2.4 EUROPE BY END-USER SEGMENTATION
18.3 KEY COUNTRIES
18.3.1 UK: MARKET SIZE & FORECAST
18.3.2 GERMANY: MARKET SIZE & FORECAST
18.3.3 FRANCE: MARKET SIZE & FORECAST
18.3.4 ITALY: MARKET SIZE & FORECAST
18.3.5 SPAIN: MARKET SIZE & FORECAST
19 APAC
19.1 MARKET OVERVIEW
19.2 MARKET SIZE & FORECAST
19.2.1 APAC BY TOOLS SEGMENTATION
19.2.2 APAC BY TECHNOLOGY SEGMENTATION
19.2.3 APAC BY APPLICATIONS SEGMENTATION
19.2.4 APAC BY END-USER SEGMENTATION
19.3 KEY COUNTRIES
19.3.1 JAPAN: MARKET SIZE & FORECAST
19.3.2 CHINA: MARKET SIZE & FORECAST
19.3.3 SOUTH KOREA: MARKET SIZE & FORECAST
19.3.4 AUSTRALIA: MARKET SIZE & FORECAST
19.3.5 INDIA: MARKET SIZE & FORECAST
20 LATIN AMERICA
20.1 MARKET OVERVIEW
20.2 MARKET SIZE & FORECAST
20.2.1 LATIN AMERICA BY TOOLS SEGMENTATION
20.2.2 LATIN AMERICA BY TECHNOLOGY SEGMENTATION
20.2.3 LATIN AMERICA BY APPLICATIONS SEGMENTATION
20.2.4 LATIN AMERICA BY END-USER SEGMENTATION
20.3 KEY COUNTRIES
20.3.1 BRAZIL: MARKET SIZE & FORECAST
20.3.2 MEXICO: MARKET SIZE & FORECAST
20.3.3 ARGENTINA: MARKET SIZE & FORECAST
21 MIDDLE EAST & AFRICA
21.1 MARKET OVERVIEW
21.2 MARKET SIZE & FORECAST
21.2.1 MIDDLE EAST & AFRICA BY TOOLS SEGMENTATION
21.2.2 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION
21.2.3 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION
21.2.4 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
21.3 KEY COUNTRIES
21.3.1 TURKEY: MARKET SIZE & FORECAST
21.3.2 SOUTH AFRICA: MARKET SIZE & FORECAST
21.3.3 SAUDI ARABIA: MARKET SIZE & FORECAST
22 COMPETITIVE LANDSCAPE
22.1 COMPETITION OVERVIEW
22.2 MARKET SHARE ANALYSIS
22.2.1 AGILENT TECHNOLOGIES
22.2.2 CODEXIS
22.2.3 EUROFINS SCIENTIFIC
22.2.4 ILLUMINA
22.2.5 NOVOZYMES
22.2.6 THERMO FISHER SCIENTIFIC
23 KEY COMPANY PROFILES
23.1 AGILENT TECHNOLOGIES
23.1.1 BUSINESS OVERVIEW
23.1.2 PRODUCT OFFERINGS
23.1.3 KEY STRATEGIES
23.1.4 KEY STRENGTHS
23.1.5 KEY OPPORTUNITIES
23.2 CODEXIS
23.2.1 BUSINESS OVERVIEW
23.2.2 PRODUCT OFFERINGS
23.2.3 KEY STRATEGIES
23.2.4 KEY STRENGTHS
23.2.5 KEY OPPORTUNITIES
23.3 EUROFINS SCIENTIFIC
23.3.1 BUSINESS OVERVIEW
23.3.2 PRODUCT OFFERINGS
23.3.3 KEY STRATEGIES
23.3.4 KEY STRENGTHS
23.3.5 KEY OPPORTUNITIES
23.4 ILLUMINA
23.4.1 BUSINESS OVERVIEW
23.4.2 PRODUCT OFFERINGS
23.4.3 KEY STRATEGIES
23.4.4 KEY STRENGTHS
23.4.5 KEY OPPORTUNITIES
23.5 NOVOZYMES
23.5.1 BUSINESS OVERVIEW
23.5.2 PRODUCT OFFERINGS
23.5.3 KEY STRATEGIES
23.5.4 KEY STRENGTHS
23.5.5 KEY OPPORTUNITIES
23.6 THERMO FISHER SCIENTIFIC
23.6.1 BUSINESS OVERVIEW
23.6.2 PRODUCT OFFERINGS
23.6.3 KEY STRATEGIES
23.6.4 KEY STRENGTHS
23.6.5 KEY OPPORTUNITIES
24 OTHER PROMINENT VENDORS
24.1 AMYRIS
24.1.1 BUSINESS OVERVIEW
24.1.2 PRODUCT OFFERINGS
24.2 ATUM
24.2.1 BUSINESS OVERVIEW
24.2.2 PRODUCT OFFERINGS
24.3 BIO-RAD LABORATORIES
24.3.1 BUSINESS OVERVIEW
24.3.2 PRODUCT OFFERINGS
24.4 CREATIVE BIOGENE
24.4.1 BUSINESS OVERVIEW
24.4.2 PRODUCT OFFERINGS
24.5 CREATIVE ENZYMES
24.5.1 BUSINESS OVERVIEW
24.5.2 PRODUCT OFFERINGS
24.6 CYRUS BIOTECHNOLOGY
24.6.1 BUSINESS OVERVIEW
24.6.2 PRODUCT OFFERINGS
24.7 EDITAS MEDICINE
24.7.1 BUSINESS OVERVIEW
24.7.2 PRODUCT OFFERINGS
24.8 GENOMATICA
24.8.1 BUSINESS OVERVIEW
24.8.2 PRODUCT OFFERINGS
24.9 GENSCRIPT
24.9.1 BUSINESS OVERVIEW
24.9.2 PRODUCT OFFERINGS
24.10 GINKGO BIOWORKS
24.10.1 BUSINESS OVERVIEW
24.10.2 PRODUCT OFFERINGS
24.11 INTEGRATED DNA TECHNOLOGIES
24.11.1 BUSINESS OVERVIEW
24.11.2 PRODUCT OFFERINGS
24.12 LUCIGEN
24.12.1 BUSINESS OVERVIEW
24.12.2 PRODUCT OFFERINGS
24.13 NEW ENGLAND BIOLABS
24.13.1 BUSINESS OVERVIEW
24.13.2 PRODUCT OFFERINGS
24.14 ORIGENE TECHNOLOGIES
24.14.1 BUSINESS OVERVIEW
24.14.2 PRODUCT OFFERINGS
24.15 PRECIGEN
24.15.1 BUSINESS OVERVIEW
24.15.2 PRODUCT OFFERINGS
24.16 SENTEBIOLAB
24.16.1 BUSINESS OVERVIEW
24.16.2 PRODUCT OFFERINGS
24.17 SYNBICITE
24.17.1 BUSINESS OVERVIEW
24.17.2 PRODUCT OFFERINGS
24.18 SYNTHEGO
24.18.1 BUSINESS OVERVIEW
24.18.2 PRODUCT OFFERINGS
24.19 TESSERA THERAPEUTICS
24.19.1 BUSINESS OVERVIEW
24.19.2 PRODUCT OFFERINGS
24.20 VIRIDOS
24.20.1 BUSINESS OVERVIEW
24.20.2 PRODUCT OFFERINGS
25 REPORT SUMMARY
25.1 KEY TAKEAWAYS
25.2 STRATEGIC RECOMMENDATIONS
26 QUANTITATIVE SUMMARY
26.1 TOOLS
26.1.1 NORTH AMERICA BY TOOLS SEGMENTATION
26.1.2 EUROPE BY TOOLS SEGMENTATION
26.1.3 APAC BY TOOLS SEGMENTATION
26.1.4 LATIN AMERICA BY TOOLS SEGMENTATION
26.1.5 MIDDLE EAST & AFRICA BY TOOLS SEGMENTATION
26.2 TECHNOLOGY
26.2.1 NORTH AMERICA BY TECHNOLOGY SEGMENTATION
26.2.2 EUROPE BY TECHNOLOGY SEGMENTATION
26.2.3 APAC BY TECHNOLOGY SEGMENTATION
26.2.4 LATIN AMERICA BY TECHNOLOGY SEGMENTATION
26.2.5 MIDDLE EAST & AFRICA BY TECHNOLOGY SEGMENTATION
26.3 APPLICATIONS
26.3.1 NORTH AMERICA BY APPLICATIONS SEGMENTATION
26.3.2 EUROPE BY APPLICATIONS SEGMENTATION
26.3.3 APAC BY APPLICATIONS SEGMENTATION
26.3.4 LATIN AMERICA BY APPLICATIONS SEGMENTATION
26.3.5 MIDDLE EAST & AFRICA BY APPLICATIONS SEGMENTATION
26.4 END-USER
26.4.1 NORTH AMERICA BY END-USER SEGMENTATION
26.4.2 EUROPE BY END-USER SEGMENTATION
26.4.3 APAC BY END-USER SEGMENTATION
26.4.4 LATIN AMERICA BY END-USER SEGMENTATION
26.4.5 MIDDLE EAST & AFRICA BY END-USER SEGMENTATION
26.5 GEOGRAPHY
26.5.1 OLIGONUCLEOTIDES & SYNTHETIC DNA SEGMENTATION BY GEOGRAPHY
26.5.2 ENZYMES SEGMENTATION BY GEOGRAPHY
26.5.3 CLONING TECHNOLOGY KITS SEGMENTATION BY GEOGRAPHY
26.5.4 XENO-NUCLEIC ACIDS SEGMENTATION BY GEOGRAPHY
26.5.5 CHASSIS ORGANISMS SEGMENTATION BY GEOGRAPHY
26.5.6 ENABLING TECHNOLOGY SEGMENTATION BY GEOGRAPHY
26.5.7 ENABLED TECHNOLOGY SEGMENTATION BY GEOGRAPHY
26.5.8 HEALTHCARE APPLICATIONS SEGMENTATION BY GEOGRAPHY
26.5.9 INDUSTRIAL APPLICATIONS SEGMENTATION BY GEOGRAPHY
26.5.10 FOOD & AGRICULTURE APPLICATIONS SEGMENTATION BY GEOGRAPHY
26.5.11 ENVIRONMENTAL APPLICATIONS SEGMENTATION BY GEOGRAPHY
26.5.12 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES SEGMENTATION BY GEOGRAPHY
26.5.13 PHARMA & BIOTECH COMPANIES SEGMENTATION BY GEOGRAPHY
26.5.14 OTHERS SEGMENTATION BY GEOGRAPHY
27 APPENDIX
27.1 ABBREVIATIONS
LIST OF EXHIBITS
EXHIBIT 1 SECTORAL USE OF SYNTHETIC BIOLOGY
EXHIBIT 2 SEGMENTATION OF GLOBAL SYNTHETIC BIOLOGY MARKET
EXHIBIT 3 MARKET SIZE CALCULATION APPROACH 2021
EXHIBIT 4 IMPORTANCE OF SYNTHETIC BIOLOGY
EXHIBIT 5 APPLICATIONS OF SYNTHETIC BIOLOGY IN DIFFERENT SECTORS
EXHIBIT 6 IMPACT OF REAL-WORLD APPLICATIONS OF SYNTHETIC BIOLOGY PRODUCTS
EXHIBIT 7 IMPACT OF SYNTHETIC BIOLOGY IN BIOMEDICINE
EXHIBIT 8 IMPACT OF SYNTHETIC DNA AS A NEW STORAGE DEVICE
EXHIBIT 9 LIFETIME, STORAGE CAPACITY, AND COST OF DIFFERENT STORAGE SYSTEMS
EXHIBIT 10 IMPACT OF RISE IN MARKET INVESTMENTS
EXHIBIT 11 Q1-Q4 INVESTMENTS IN SYNTHETIC BIOLOGY IN 2021
EXHIBIT 12 INVESTMENT DEALS IN SYNTHETIC BIOLOGY BY DIFFERENT INDUSTRY SECTORS (2021)
EXHIBIT 13 IMPACT OF STRATEGIC COLLABORATIONS & ACQUISITIONS TO DEVELOP MULTIFUNCTIONAL PRODUCTS
EXHIBIT 14 IMPACT OF TRANSFORMATIVE SYNTHETIC BIOLOGY TECHNOLOGIES IN AGRICULTURE
EXHIBIT 15 IMPACT OF MISUSE OF SYNTHETIC BIOLOGY
EXHIBIT 16 SYNTHETIC BIOLOGY CAPABILITIES ACCORDING TO HIGH-LOW CONCERN LEVELS
EXHIBIT 17 IMPACT OF SYNTHETIC BIOLOGY-INDUCED CHANGES IN GLOBAL BIOSECURITY FRAMEWORK
EXHIBIT 18 TIMELINE SHOWING EXPANSION OF GLOBAL USERS OF GENETIC ENGINEERING & SYNTHETIC BIOLOGY
EXHIBIT 19 IMPACT OF THREAT TO EXISTING TECHNOLOGIES
EXHIBIT 20 GLOBAL SYNTHETIC BIOLOGY MARKET 2021–2027 ($ MILLION)
EXHIBIT 21 GLOBAL SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY
EXHIBIT 22 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS
EXHIBIT 23 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY
EXHIBIT 24 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATION
EXHIBIT 25 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER
EXHIBIT 26 FIVE FORCES ANALYSIS 2021
EXHIBIT 27 INCREMENTAL GROWTH BY TOOLS 2021 & 2027
EXHIBIT 28 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS
EXHIBIT 29 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS: OVERVIEW
EXHIBIT 30 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS: INCREMENTAL GROWTH
EXHIBIT 31 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS: ABSOLUTE GROWTH
EXHIBIT 32 THE CHARACTERISTICS OF OLIGONUCLEOTIDES DESIRABLE FOR EFFICIENT PCR PRIMERS
EXHIBIT 33 GLOBAL SYNTHETIC BIOLOGY MARKET BY OLIGONUCLEOTIDES & SYNTHETIC DNA: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 34 GLOBAL SYNTHETIC BIOLOGY MARKET BY OLIGONUCLEOTIDES & SYNTHETIC DNA 2021–2027 ($ BILLION)
EXHIBIT 35 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 36 VARIOUS APPLICATIONS OF SYNTHETIC ENZYMES
EXHIBIT 37 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENZYMES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 38 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENZYMES 2021–2027 ($ BILLION)
EXHIBIT 39 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 40 GLOBAL SYNTHETIC BIOLOGY MARKET BY CLONING TECHNOLOGY KITS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 41 APPLICATIONS OF DNA CLONING
EXHIBIT 42 GLOBAL SYNTHETIC BIOLOGY MARKET BY CLONING TECHNOLOGY KITS 2021–2027 ($ BILLION)
EXHIBIT 43 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 44 GLOBAL SYNTHETIC BIOLOGY MARKET BY XENO-NUCLEIC ACIDS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 45 GLOBAL SYNTHETIC BIOLOGY MARKET BY XENO-NUCLEIC ACIDS 2021–2027 ($ BILLION)
EXHIBIT 46 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 47 GLOBAL SYNTHETIC BIOLOGY MARKET BY CHASSIS ORGANISMS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 48 GLOBAL SYNTHETIC BIOLOGY MARKET BY CHASSIS ORGANISMS 2021–2027 ($ BILLION)
EXHIBIT 49 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 50 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 51 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY
EXHIBIT 52 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY: INCREMENTAL GROWTH
EXHIBIT 53 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY: OVERVIEW
EXHIBIT 54 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY: ABSOLUTE GROWTH
EXHIBIT 55 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLING TECHNOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 56 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLING TECHNOLOGY 2021–2027 ($ BILLION)
EXHIBIT 57 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 58 BENEFITS OF NGS
EXHIBIT 59 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLED TECHNOLOGY: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 60 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENABLED TECHNOLOGY 2021–2027 ($ BILLION)
EXHIBIT 61 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 62 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 63 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS
EXHIBIT 64 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS: INCREMENTAL GROWTH
EXHIBIT 65 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS: OVERVIEW
EXHIBIT 66 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS: ABSOLUTE GROWTH
EXHIBIT 67 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS: GROWTH ANALYSIS
EXHIBIT 68 GLOBAL SYNTHETIC BIOLOGY MARKET BY HEALTHCARE APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 69 GLOBAL SYNTHETIC BIOLOGY MARKET BY HEALTHCARE APPLICATIONS 2021–2027 ($ BILLION)
EXHIBIT 70 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 71 MAJOR EXAMPLES OF CHEMICALS PRODUCED THROUGH SYNTHETIC BIOLOGY
EXHIBIT 72 GLOBAL SYNTHETIC BIOLOGY MARKET BY INDUSTRIAL APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 73 GLOBAL SYNTHETIC BIOLOGY MARKET BY INDUSTRIAL APPLICATIONS 2021–2027 ($ BILLION)
EXHIBIT 74 ADVANTAGES OF SYNTHETIC BIOLOGY STRATEGIES TO BIOENERGY SECTOR
EXHIBIT 75 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 76 GLOBAL AREA COVERED BY GM CROPS 2017 (%)
EXHIBIT 77 GLOBAL SYNTHETIC BIOLOGY MARKET BY FOOD & AGRICULTURE APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 78 GLOBAL SYNTHETIC BIOLOGY MARKET BY FOOD & AGRICULTURE APPLICATIONS 2021–2027 ($ BILLION)
EXHIBIT 79 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 80 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENVIRONMENTAL APPLICATIONS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 81 ADVANTAGES OF SYNTHETIC BIOLOGY STRATEGIES FOR ENVIRONMENTAL CONSERVATION
EXHIBIT 82 GLOBAL SYNTHETIC BIOLOGY MARKET BY ENVIRONMENTAL APPLICATIONS 2021–2027 ($ BILLION)
EXHIBIT 83 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 84 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 85 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER
EXHIBIT 86 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USERS: INCREMENTAL GROWTH
EXHIBIT 87 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER: MARKET OVERVIEW
EXHIBIT 88 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER: ABSOLUTE GROWTH
EXHIBIT 89 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER: GROWTH ANALYSIS
EXHIBIT 90 GLOBAL SYNTHETIC BIOLOGY MARKET BY ACADEMIC/RESEARCH INSTITUTES & LABORATORIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 91 GLOBAL SYNTHETIC BIOLOGY MARKET BY ACADEMIC/RESEARCH INSTITUTES & LABORATORIES 2021–2027 ($ BILLION)
EXHIBIT 92 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 93 GLOBAL SYNTHETIC BIOLOGY MARKET BY PHARMA & BIOTECH COMPANIES: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 94 TOTAL GLOBAL REGENERATIVE MEDICINE AND ADVANCED THERAPY DEVELOPERS 2021
EXHIBIT 95 GLOBAL SYNTHETIC BIOLOGY MARKET BY PHARMA & BIOTECH COMPANIES 2021–2027 ($ BILLION)
EXHIBIT 96 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 97 GLOBAL SYNTHETIC BIOLOGY MARKET BY OTHERS: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 98 GLOBAL SYNTHETIC BIOLOGY MARKET BY OTHERS 2021–2027 ($ BILLION)
EXHIBIT 99 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 100 INCREMENTAL GROWTH BY GEOGRAPHY 2021 & 2027
EXHIBIT 101 GLOBAL SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY
EXHIBIT 102 GLOBAL SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY: INCREMENTAL GROWTH
EXHIBIT 103 GLOBAL SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY: ABSOLUTE GROWTH
EXHIBIT 104 SYNTHETIC BIOLOGY MARKET IN NORTH AMERICA: KEY COUNTRIES 2021
EXHIBIT 105 SYNTHETIC BIOLOGY MARKET IN NORTH AMERICA: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 106 SYNTHETIC BIOLOGY MARKET IN NORTH AMERICA 2021–2027 ($ BILLION)
EXHIBIT 107 INCREMENTAL GROWTH BY TOOLS 2021 & 2027
EXHIBIT 108 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 109 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 110 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 111 INCREMENTAL GROWTH IN NORTH AMERICA 2021 & 2027
EXHIBIT 112 SYNTHETIC BIOLOGY MARKET IN US 2021–2027 ($ BILLION)
EXHIBIT 113 SYNTHETIC BIOLOGY MARKET IN CANADA 2021–2027 ($ BILLION)
EXHIBIT 114 PHARMA & BIOTECH COMPANIES INVOLVED IN R&D ACTIVITIES IN US, EUROPE, AND CHINA 2019
EXHIBIT 115 SYNTHETIC BIOLOGY MARKET IN EUROPE: KEY COUNTRIES 2021
EXHIBIT 116 SYNTHETIC BIOLOGY MARKET IN EUROPE: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 117 SYNTHETIC BIOLOGY MARKET IN EUROPE 2021–2027 ($ BILLION)
EXHIBIT 118 INCREMENTAL GROWTH BY TOOLS 2021 & 2027
EXHIBIT 119 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 120 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 121 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 122 INCREMENTAL GROWTH IN EUROPE 2021 & 2027
EXHIBIT 123 SYNTHETIC BIOLOGY MARKET IN UK 2021–2027 ($ BILLION)
EXHIBIT 124 TIMELINE OF SYNTHETIC BIOLOGY IN THE CONTEXT OF THE GERMAN ASSOCIATION FOR SYNTHETIC BIOLOGY
EXHIBIT 125 SYNTHETIC BIOLOGY MARKET IN GERMANY 2021–2027 ($ BILLION)
EXHIBIT 126 SYNTHETIC BIOLOGY MARKET IN FRANCE 2021–2027 ($ BILLION)
EXHIBIT 127 SYNTHETIC BIOLOGY MARKET IN ITALY 2021–2027 ($ BILLION)
EXHIBIT 128 SYNTHETIC BIOLOGY MARKET IN SPAIN 2021–2027 ($ BILLION)
EXHIBIT 129 SYNTHETIC BIOLOGY MARKET IN APAC: KEY COUNTRIES 2021
EXHIBIT 130 SYNTHETIC BIOLOGY MARKET IN APAC: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 131 SYNTHETIC BIOLOGY MARKET IN APAC 2021–2027 ($ BILLION)
EXHIBIT 132 INCREMENTAL GROWTH BY TOOLS 2021 & 2027
EXHIBIT 133 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 134 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 135 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 136 INCREMENTAL GROWTH IN APAC 2021 & 2027
EXHIBIT 137 SYNTHETIC BIOLOGY MARKET IN JAPAN 2021–2027 ($ BILLION)
EXHIBIT 138 SYNTHETIC BIOLOGY MARKET IN CHINA 2021–2027 ($ BILLION)
EXHIBIT 139 SYNTHETIC BIOLOGY MARKET IN SOUTH KOREA 2021–2027 ($ BILLION)
EXHIBIT 140 SYNTHETIC BIOLOGY MARKET IN AUSTRALIA 2021–2027 ($ BILLION)
EXHIBIT 141 SYNTHETIC BIOLOGY MARKET IN INDIA 2021–2027 ($ BILLION)
EXHIBIT 142 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA: KEY COUNTRIES 2021
EXHIBIT 143 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 144 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA 2021–2027 ($ BILLION)
EXHIBIT 145 INCREMENTAL GROWTH BY TOOLS 2021 & 2027
EXHIBIT 146 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 147 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 148 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 149 INCREMENTAL GROWTH IN LATIN AMERICA 2021 & 2027
EXHIBIT 150 SYNTHETIC BIOLOGY MARKET IN BRAZIL 2021–2027 ($ BILLION)
EXHIBIT 151 SYNTHETIC BIOLOGY MARKET IN MEXICO 2021–2027 ($ BILLION)
EXHIBIT 152 SYNTHETIC BIOLOGY MARKET IN ARGENTINA 2021–2027 ($ BILLION)
EXHIBIT 153 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET: KEY COUNTRIES 2021
EXHIBIT 154 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET: INCREMENTAL & ABSOLUTE GROWTH
EXHIBIT 155 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA 2021–2027 ($ BILLION)
EXHIBIT 156 INCREMENTAL GROWTH BY TOOLS 2021 & 2027
EXHIBIT 157 INCREMENTAL GROWTH BY TECHNOLOGY 2021 & 2027
EXHIBIT 158 INCREMENTAL GROWTH BY APPLICATIONS 2021 & 2027
EXHIBIT 159 INCREMENTAL GROWTH BY END-USER 2021 & 2027
EXHIBIT 160 INCREMENTAL GROWTH IN MIDDLE EAST & AFRICA 2021 & 2027
EXHIBIT 161 SYNTHETIC BIOLOGY MARKET IN TURKEY 2021–2027 ($ BILLION)
EXHIBIT 162 SOUTH AFRICA SYNTHETIC BIOLOGY MARKET 2021–2027 ($ BILLION)
EXHIBIT 163 SYNTHETIC BIOLOGY MARKET IN SAUDI ARABIA 2021–2027 ($ BILLION)
EXHIBIT 164 PURE & DIVERSIFIED VENDORS IN GLOBAL SYNTHETIC BIOLOGY MARKET
EXHIBIT 165 VENDORS OFFERING COMMERCIAL SYNTHETIC BIOLOGY PRODUCTS: MARKET DOMINANCE ANALYSIS
EXHIBIT 166 KEY VENDORS OFFERING COMMERCIAL SYNTHETIC BIOLOGY PRODUCTS: CAPABILITIES & EXPERTISE ASSESSMENT
EXHIBIT 167 AGILENT TECHNOLOGIES: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 168 AGILENT TECHNOLOGIES: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 169 AGILENT TECHNOLOGIES: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 170 AGILENT TECHNOLOGIES: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
EXHIBIT 171 CODEXIS: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 172 CODEXIS: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 173 CODEXIS: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 174 CODEXIS: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
EXHIBIT 175 EUROFINS SCIENTIFIC: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 176 EUROFINS SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
EXHIBIT 177 ILLUMINA: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 178 ILLUMINA: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 179 ILLUMINA: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 180 NOVOZYMES: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 181 NOVOZYMES: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 182 NOVOZYMES: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 183 THERMO FISHER SCIENTIFIC: TOTAL REVENUE 2019–2021 ($ MILLION)
EXHIBIT 184 THERMO FISHER SCIENTIFIC: R&D EXPENDITURE 2019–2021 ($ MILLION)
EXHIBIT 185 THERMO FISHER SCIENTIFIC: REVENUE BY BUSINESS SEGMENT 2020–2021 ($ MILLION)
EXHIBIT 186 THERMO FISHER SCIENTIFIC: REVENUE BY GEOGRAPHY 2021 ($ MILLION)
LIST OF TABLES
TABLE 1 KEY CAVEATS
TABLE 2 CURRENCY CONVERSION 2015–2021
TABLE 3 APPROVED GENE THERAPY PRODUCTS 2019–2021
TABLE 4 DNA VS. CHEMICAL-BASED METHODS FOR INFORMATION TECHNOLOGY APPLICATIONS
TABLE 5 EVOLUTION OF DNA AS DATA STORAGE
TABLE 6 EXAMPLES OF INVESTMENTS IN RECENT YEARS
TABLE 7 RECENT COLLABORATIONS IN GLOBAL SYNTHETIC BIOLOGY MARKET
TABLE 8 RECENT ACQUISITIONS IN GLOBAL SYNTHETIC BIOLOGY MARKET
TABLE 9 OLIGONUCLEOTIDES & SYNTHETIC DNA IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 10 OLIGONUCLEOTIDES & SYNTHETIC DNA IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 11 ENZYME CLASSES, TYPES OF REACTIONS, AND CORRESPONDING ENZYMES
TABLE 12 ENZYMES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 13 ENZYMES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 14 CLONING TECHNOLOGY KITS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 15 CLONING TECHNOLOGY KITS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 16 XENO-NUCLEIC ACIDS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 17 XENO-NUCLEIC ACIDS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 18 CHARACTERISTICS OF MICROBIAL CHASSIS
TABLE 19 CHASSIS ORGANISMS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 20 CHASSIS ORGANISMS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 21 ENABLING TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 22 ENABLING TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 23 ENABLED TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 24 ENABLED TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 25 HEALTHCARE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 26 HEALTHCARE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 27 INDUSTRIAL APPLICATIONS OF MICROBIAL ENZYMES
TABLE 28 INDUSTRIAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 29 INDUSTRIAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 30 REFORMATION & REVOLUTION OF FOOD INDUSTRY BY SYNTHETIC BIOLOGY
TABLE 31 FOOD & AGRICULTURE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 32 FOOD & AGRICULTURE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 33 ENVIRONMENTAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 34 ENVIRONMENTAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 35 GLOBAL UNIVERSITIES FOR MOLECULAR BIOLOGY & GENETICS
TABLE 36 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 37 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 38 TOP COUNTRIES WITH GENOMICS FIRMS
TABLE 39 PHARMA & BIOTECH COMPANIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 40 PHARMA & BIOTECH COMPANIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 41 OTHERS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 42 OTHERS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 43 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 44 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 45 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 46 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 47 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 48 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 49 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 50 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 51 SYNTHETIC BIOLOGY MARKET IN EUROPE BY TOOLS 2021–2027 ($ BILLION)
TABLE 52 SYNTHETIC BIOLOGY MARKET IN EUROPE BY TOOLS 2021–2027 (%)
TABLE 53 SYNTHETIC BIOLOGY MARKET IN EUROPE BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 54 SYNTHETIC BIOLOGY MARKET IN EUROPE BY TECHNOLOGY 2021–2027 (%)
TABLE 55 SYNTHETIC BIOLOGY MARKET IN EUROPE BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 56 SYNTHETIC BIOLOGY MARKET IN EUROPE BY APPLICATIONS 2021–2027 (%)
TABLE 57 SYNTHETIC BIOLOGY MARKET IN EUROPE BY END-USER 2021–2027 ($ BILLION)
TABLE 58 SYNTHETIC BIOLOGY MARKET IN EUROPE BY END-USER 2021–2027 (%)
TABLE 59 SYNTHETIC BIOLOGY MARKET IN APAC BY TOOLS 2021–2027 ($ BILLION)
TABLE 60 SYNTHETIC BIOLOGY MARKET IN APAC BY TOOLS 2021–2027 (%)
TABLE 61 SYNTHETIC BIOLOGY MARKET IN APAC BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 62 SYNTHETIC BIOLOGY MARKET IN APAC BY TECHNOLOGY 2021–2027 (%)
TABLE 63 SYNTHETIC BIOLOGY MARKET IN APAC BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 64 SYNTHETIC BIOLOGY MARKET IN APAC BY APPLICATIONS 2021–2027 (%)
TABLE 65 SYNTHETIC BIOLOGY MARKET IN APAC BY END-USER 2021–2027 ($ BILLION)
TABLE 66 SYNTHETIC BIOLOGY MARKET IN APAC BY END-USER 2021-2027 (%)
TABLE 67 AUSTRALIAN INDUSTRY EXPECTED GROWTH IN SYNTHETIC BIOLOGY BY 2040
TABLE 68 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY TOOLS 2021–2027 ($ BILLION)
TABLE 69 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY TOOLS 2021–2027 (%)
TABLE 70 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 71 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY TECHNOLOGY 2021–2027 (%)
TABLE 72 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 73 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY APPLICATIONS 2021–2027 (%)
TABLE 74 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY END-USER 2021–2027 ($ BILLION)
TABLE 75 SYNTHETIC BIOLOGY MARKET IN LATIN AMERICA BY END-USER 2021–2027 (%)
TABLE 76 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY TOOLS 2021–2027 ($ BILLION)
TABLE 77 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY TOOLS 2021–2027 (%)
TABLE 78 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 79 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY TECHNOLOGY 2021–2027 (%)
TABLE 80 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 81 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY APPLICATIONS 2021–2027 (%)
TABLE 82 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY END-USER 2021–2027 ($ BILLION)
TABLE 83 SYNTHETIC BIOLOGY MARKET IN MIDDLE EAST & AFRICA BY END-USER 2021–2027 (%)
TABLE 84 AGILENT TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 85 CODEXIS: MAJOR PRODUCT OFFERINGS
TABLE 86 EUROFINS SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 87 ILLUMINA: MAJOR PRODUCT OFFERINGS
TABLE 88 NOVOZYMES: MAJOR PRODUCT OFFERINGS
TABLE 89 THERMO FISHER SCIENTIFIC: MAJOR PRODUCT OFFERINGS
TABLE 90 AMYRIS: MAJOR PRODUCT OFFERINGS
TABLE 91 ATUM: MAJOR PRODUCT OFFERINGS
TABLE 92 BIO-RAD LABORATORIES: MAJOR PRODUCT OFFERINGS
TABLE 93 CREATIVE BIOGENE: MAJOR PRODUCT OFFERINGS
TABLE 94 CREATIVE ENZYMES: MAJOR PRODUCT OFFERINGS
TABLE 95 CYRUS BIOTECHNOLOGY: MAJOR PRODUCT OFFERINGS
TABLE 96 EDITAS MEDICINE: MAJOR PRODUCT OFFERINGS
TABLE 97 GENOMATICA: MAJOR PRODUCT OFFERINGS
TABLE 98 GENSCRIPT: MAJOR PRODUCT OFFERINGS
TABLE 99 GINKGO BIOWORKS: MAJOR PRODUCT OFFERINGS
TABLE 100 INTEGRATED DNA TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 101 LUCIGEN: MAJOR PRODUCT OFFERINGS
TABLE 102 NEW ENGLAND BIOLABS: MAJOR PRODUCT OFFERINGS
TABLE 103 ORIGENE TECHNOLOGIES: MAJOR PRODUCT OFFERINGS
TABLE 104 PRECIGEN: MAJOR PRODUCT OFFERINGS
TABLE 105 SENTEBIOLAB: MAJOR PRODUCT OFFERINGS
TABLE 106 SYNBICITE: MAJOR PRODUCT OFFERINGS
TABLE 107 SYNTHEGO: MAJOR PRODUCT OFFERINGS
TABLE 108 TESSERA THERAPEUTICS: MAJOR PRODUCT OFFERINGS
TABLE 109 VIRIDOS: MAJOR PRODUCT OFFERINGS
TABLE 110 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 111 GLOBAL SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 112 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 113 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 114 EUROPE SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 115 EUROPE SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 116 APAC SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 117 APAC SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 118 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 119 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 120 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 ($ BILLION)
TABLE 121 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY TOOLS 2021–2027 (%)
TABLE 122 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 123 GLOBAL SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 124 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 125 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 126 EUROPE SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 127 EUROPE SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 128 APAC SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 129 APAC SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 130 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 131 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 132 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 ($ BILLION)
TABLE 133 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY TECHNOLOGY 2021–2027 (%)
TABLE 134 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 135 GLOBAL SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 136 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 137 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 138 EUROPE SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 139 EUROPE SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 140 APAC SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 141 APAC SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 142 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 143 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 144 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 ($ BILLION)
TABLE 145 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY APPLICATIONS 2021–2027 (%)
TABLE 146 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 147 GLOBAL SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 148 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 149 NORTH AMERICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 150 EUROPE SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 151 EUROPE SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 152 APAC SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 153 APAC SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 154 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 155 LATIN AMERICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 156 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 ($ BILLION)
TABLE 157 MIDDLE EAST & AFRICA SYNTHETIC BIOLOGY MARKET BY END-USER 2021–2027 (%)
TABLE 158 GLOBAL SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 159 GLOBAL SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 160 OLIGONUCLEOTIDES & SYNTHETIC DNA IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 161 OLIGONUCLEOTIDES & SYNTHETIC DNA IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 162 ENZYMES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 163 ENZYMES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 164 CLONING TECHNOLOGY KITS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 165 CLONING TECHNOLOGY KITS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 166 XENO-NUCLEIC ACIDS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 167 XENO-NUCLEIC ACIDS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 168 CHASSIS ORGANISMS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 169 CHASSIS ORGANISMS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 170 ENABLING TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 171 ENABLING TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 172 ENABLED TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 173 ENABLED TECHNOLOGY IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 174 HEALTHCARE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 175 HEALTHCARE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 176 INDUSTRIAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 177 INDUSTRIAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 178 FOOD & AGRICULTURE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 179 FOOD & AGRICULTURE APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 180 ENVIRONMENTAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 181 ENVIRONMENTAL APPLICATIONS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 182 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 183 ACADEMIC/RESEARCH INSTITUTES & LABORATORIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 184 PHARMA & BIOTECH COMPANIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 185 PHARMA & BIOTECH COMPANIES IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
TABLE 186 OTHERS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 ($ BILLION)
TABLE 187 OTHERS IN SYNTHETIC BIOLOGY MARKET BY GEOGRAPHY 2021–2027 (%)
Single User Licence
5 User Licence
Corporate Licence
Datasheet Licence
"The report by Arizton was spot on. It not only gave us insight into the pro audio market, we used it to raise funds for our company. The data proved (to the VC we pitched to) that the market was large enough for our company to not only survive but also grow."
